SynthesisBMC cancer2022

Combined atezolizumab and nab-paclitaxel in the treatment of triple negative breast cancer: a meta-analysis on their efficacy and safety.

K Sharmni Vishnu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.